During the past decade, Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology" are "Multiple Sclerosis" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology" in a lesser frequency.

Most popular intervention types in "Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Interferon beta-1a" (1 trials), "Interferon beta-1a-matching placebo" (1 trials) and "Ocrelizumab-matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".